Science and Health

FDA Panel To Consider Moderna, J&J Boosters

The committee's advice will help the FDA determine whether to authorize the boosters.

FDA Panel To Consider Moderna, J&J Boosters
Mark Lennihan / AP
SMS

An FDA advisory committee is meeting today to consider data on booster doses for the Moderna and Johnson & Johnson vaccines. 

The committee's advice will help the FDA determine whether to authorize the boosters. 

Joining us now is Newsy White House correspondent Kellan Howell with more.